Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects
Clinical trial NCT03345043 · COMPLETED
Trial details
- NCT number
- NCT03345043
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-11
- Primary completion
- 2018-08-13
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.